December 7, 2020December 7, 2020

Onconova Seeking FDA Approval for Phase 1 Trial of ON 123300 for Breast Cancer

News

Onconova Therapeutics is seeking the green light from the U.S. Food and Drug Administration (FDA) to begin a Phase 1 clinical trial for its small molecule ON 123300 in certain ... Read more

March 2, 2015March 2, 2015

Palbociclib Efficient in Patients with Hormone-Resistant Breast Cancer

News

Encouraging results from a Phase II clinical trial of Palbociclib for the treatment of advanced breast cancer patients were published this month in Clinical Cancer Research. Palbociclib is an experimental oral ... Read more